Abivax
Abivax is a viral diseases founded in 2013.
2
Funding Rounds
$62.7m
Money raised
Funding series
Funding Series Analysis
The company Abivax has raised a total of $49.15m in funding over 2 rounds.
Key Insights:
- Abivax - Post-IPO Debt, September 2022: $49.15m
- Abivax funding round, July 2019: $13.5m
Abivax - Post-IPO Debt, September 2022
$49.15m
Abivax funding round, July 2019
$13.5m
Industries
Abivax is active in the following industries: